BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37458302)

  • 1. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
    Obiorah IE; Upadhyaya KD; Calvo KR
    Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
    Carraway HE; LaFramboise T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary myeloid malignancies.
    Rafei H; DiNardo CD
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid Neoplasms with Germline Predisposition.
    Geyer JT
    Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Germline Predisposition to Myeloid Neoplasms.
    Thompson C; Ariagno S; Kohorst MA
    Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer predisposition syndromes associated with myeloid malignancy.
    Quinn E; Nichols KE
    Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
    Friend P; Mahon SM
    Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.
    Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2021 Aug; 16(4):336-344. PubMed ID: 34028637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
    Trottier AM; Feurstein S; Godley LA
    Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
    Reinig EF; Rubinstein JD; Patil AT; Schussman AL; Horner VL; Kanagal-Shamanna R; Churpek JE; Matson DR
    Leukemia; 2023 Aug; 37(8):1589-1599. PubMed ID: 37393344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
    Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
    Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic predisposition to pediatric myeloid malignancies].
    Muramatsu H
    Rinsho Ketsueki; 2016 Jun; 57(6):730-5. PubMed ID: 27384852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.